Is PGT-M a Realistic Option When Both Partners Carry Wilson Disease?

When both partners in a couple are carriers of Wilson disease, there is a one-in-four chance with each pregnancy that the child will have the disease. That probability does not change based on what happened in previous pregnancies — every conception starts fresh at 25%. That reality leads many couples to ask a very practical question: can we use embryo testing to avoid passing this on?

The short answer is yes, preimplantation genetic testing for monogenic disease (PGT-M) is a real and increasingly used option for autosomal recessive conditions like Wilson disease, and it does work for carrier couples.¹ But it is genuinely demanding — physically, emotionally, and often financially — and conceiving naturally and testing after birth is a legitimate alternative that many couples choose. This post will walk through what both paths actually involve, so you can have an informed conversation with a reproductive specialist.

What PGT-M actually is

PGT-M (preimplantation genetic testing for monogenic disorders) is a laboratory process performed as part of an in vitro fertilization (IVF) cycle. Eggs are retrieved after hormone stimulation, fertilized in the laboratory, and the resulting embryos are grown for five to six days to the blastocyst stage. At that point, a small number of cells (usually five to eight) are biopsied from each embryo without destroying it, and those cells are analyzed for the specific genetic variant you are testing for.²

For Wilson disease, the laboratory needs to know the specific ATP7B variants carried by both partners. Because Wilson disease has over 900 known mutations and the relevant mutation varies between families, the laboratory typically spends several weeks before the IVF cycle designing a custom test — called a “probe” — tailored to your family’s specific mutations.¹ This design phase is part of what makes PGT-M more time-intensive than some couples expect.

Embryos that do not carry two faulty copies — meaning they are either unaffected or carriers like you — are considered suitable for transfer. Embryos with two faulty copies (which would develop Wilson disease) are not transferred.

The realistic picture of an IVF/PGT-M cycle

PGT-M requires IVF, which means it involves hormone injections, egg retrieval under sedation, and laboratory embryo culture. The process takes weeks per cycle, and not every cycle produces transferable embryos — embryo numbers, fertilization rates, and biopsy results all create uncertainty.

A few honest realities for carrier couples:

• Not all embryos will be unaffected: Statistically, 25% of embryos will have Wilson disease, 50% will be carriers (which is fine), and 25% will be completely unaffected. In practice, with a small number of embryos, you may end up with zero transferable embryos in a given cycle simply by chance.
• Success rates depend on age: Live birth rates per embryo transfer in IVF cycles vary significantly with the mother’s age. For women in their mid-twenties to early thirties, per-transfer success rates are generally higher than for women in their late thirties or forties.³
• Multiple cycles are often needed: Families pursuing PGT-M often need more than one IVF cycle to achieve a pregnancy, which multiplies both the physical demands and the cost.
• The process takes months: Between the design phase, hormone stimulation, retrieval, biopsy, genetic analysis, and then the embryo transfer cycle (which may be a separate frozen transfer cycle), six to twelve months from consultation to pregnancy is common.²

What natural conception with postnatal testing looks like

The alternative — conceiving naturally and testing the baby after birth — is also a legitimate, common choice. The statistical reality is that 75% of naturally conceived pregnancies in a carrier-carrier couple will result in an unaffected child or a carrier. The concern is the 25% that will have Wilson disease.

Wilson disease is a treatable condition. Children diagnosed early — before significant organ damage occurs — do very well on chelation or zinc therapy.⁴ The disease is not immediately life-threatening from birth, and newborns do not typically show symptoms for years. This means there is a meaningful window for early diagnosis and treatment.

Postnatal testing options include:

• Newborn genetic testing: If both parents’ mutations are known (which they would be if you have already been through a genetic workup), your genetic counselor can arrange testing from a newborn blood sample. This is straightforward, fast, and low cost compared to IVF.
• Screening labs: Ceruloplasmin and liver function tests can also be checked in infancy, though they are not as definitive as genetic testing and may be normal even in affected children in the first years of life.

Many families in this situation choose natural conception for their first pregnancy, knowing that if the child is diagnosed with Wilson disease, treatment is available and the outlook with good management is positive. See our general posts on Wilson disease and family screening for more on what that management looks like.

Prenatal testing during pregnancy — a middle option

A third path exists: conceive naturally, and then test the fetus during pregnancy using chorionic villus sampling (CVS) at around ten to thirteen weeks, or amniocentesis at around fifteen to twenty weeks. Both procedures carry a small procedural risk of miscarriage — this is a real consideration that should be discussed with your obstetrician and genetic counselor.

If prenatal testing shows the fetus has Wilson disease, families face a decision about whether to continue the pregnancy. This is deeply personal and depends on values, beliefs, and circumstances. Some families find having this information useful for preparing for early treatment; others prefer not to test prenatally. None of these options is objectively right or wrong.

Which path is right for your situation?

There is no universal answer, and your genetic counselor and reproductive specialist are the right people to help you work through the specifics. Factors that often shape the decision:

Factor	Tends toward PGT-M	Tends toward natural + postnatal testing
Age	Under 35 (better IVF outcomes)	Any age
Family history severity	Severe neurological presentation in family	Hepatic, well-controlled disease
Emotional stance on diagnosis in child	Strong preference to avoid	Comfortable with early diagnosis and treatment
Financial coverage	Insurance covers IVF/PGT	No coverage; significant out-of-pocket cost
Fertility	No known fertility issues	No known fertility issues
Time	Can invest 1+ years	Want to conceive soon

Finding a centre that offers PGT-M for Wilson disease

PGT-M for Wilson disease requires a fertility clinic with an in-house or partner genetics laboratory experienced in monogenic disease testing. Not all IVF clinics offer this service. In North America and Europe, specialized centres do exist — your Wilson disease specialist or a genetic counselor can help with referrals. The process always begins with a genetic counseling appointment to confirm your specific mutations and assess feasibility before the laboratory design work starts.¹

This article is patient education, not medical advice. Decisions about family planning with Wilson disease involve medical, genetic, emotional, and personal factors that are specific to each couple. Please consult a genetic counselor and a reproductive specialist before making any family planning decisions.

References